Troendle August J. (CIK 1622058) reported 22 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-04). Recent activity: Sell MEDP (668 shares), Sell MEDP (23,178 shares), Sell MEDP (5,698 shares), Sell MEDP (41,331 shares), Sell MEDP (15,151 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-04 | Medpace Holdings, Inc. (MEDP) | CEO | Sell | 668 | $394,581 |
| 2025-12-03 | Medpace Holdings, Inc. (MEDP) | CEO | Sell | 23,178 | $13.8M |
| 2025-12-03 | Medpace Holdings, Inc. (MEDP) | CEO | Sell | 5,698 | $3.4M |
| 2025-12-01 | Medpace Holdings, Inc. (MEDP) | CEO | Sell | 41,331 | $25.1M |
| 2025-12-01 | Medpace Holdings, Inc. (MEDP) | CEO | Sell | 15,151 | $9.0M |
| 2025-11-26 | Medpace Holdings, Inc. (MEDP) | CEO | Sell | 59,025 | $35.9M |
| 2025-11-26 | Medpace Holdings, Inc. (MEDP) | CEO | Sell | 42,392 | $26.1M |
| 2025-11-24 | Medpace Holdings, Inc. (MEDP) | CEO | Sell | 6,830 | $4.1M |
| 2025-11-24 | Medpace Holdings, Inc. (MEDP) | CEO | Sell | 21,858 | $12.9M |
| 2025-11-20 | Medpace Holdings, Inc. (MEDP) | CEO | Sell | 7,191 | $4.2M |
| 2025-11-20 | Medpace Holdings, Inc. (MEDP) | CEO | Sell | 23,862 | $14.1M |
| 2025-11-18 | Medpace Holdings, Inc. (MEDP) | CEO | Sell | 14,747 | $8.8M |
| 2025-11-18 | Medpace Holdings, Inc. (MEDP) | CEO | Sell | 6,047 | $3.6M |
| 2025-11-14 | Medpace Holdings, Inc. (MEDP) | CEO | Sell | 5,312 | $3.2M |
| 2025-11-14 | Medpace Holdings, Inc. (MEDP) | CEO | Sell | 5,128 | $3.1M |
| 2025-09-03 | Medpace Holdings, Inc. (MEDP) | CEO | Sell | 36,196 | $17.2M |
| 2025-09-03 | Medpace Holdings, Inc. (MEDP) | CEO | Sell | 1,197 | $568,707 |
| 2025-08-28 | Medpace Holdings, Inc. (MEDP) | CEO | Sell | 620 | $294,500 |
| 2025-07-29 | Medpace Holdings, Inc. (MEDP) | CEO | Sell | 48,487 | $21.9M |
| 2025-03-10 | Medpace Holdings, Inc. (MEDP) | CEO | Buy | 37,417 | $2.0M |
| 2025-03-10 | Medpace Holdings, Inc. (MEDP) | CEO | Buy | 234,259 | $13.3M |
| 2025-03-10 | Medpace Holdings, Inc. (MEDP) | CEO | Buy | 84,770 | $9.1M |
Source: SEC Form 4 filings · as of 2025-12-04